454 Checkpoint modification of early T cell activation provides enhanced anti-tumor activity and survival benefits in a fast-growing preclinical tumor challenge model

454 Checkpoint modification of early T cell activation provides enhanced anti-tumor activity and survival benefits in a fast-growing preclinical tumor challenge model

Bibliographic Details
Main Authors: Sue L Currie, Mohsen Mohammadi, Xiang Y Zhou, Zhi Xiang, Wynetta Giles-Davis, Andrew Luber, Hildegund CJ Ertl
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:Journal for ImmunoTherapy of Cancer

Similar Items